Goldman Sachs Sees 100% Upside In This Biopharma Company By: Benzinga via Benzinga March 05, 2018 at 15:30 PM EST Revance Therapeutics Inc (NASDAQ: RVNC) has dropped 9 percent since the start of the year, but it's begun a path to redemption ... Read More >> Related Stocks: Allergan Plc Revance Therapeutics